En español
NIDA

People with HIV or AIDS

Journal issue explores early interventions to prevent risky sexual behaviors related to HIV/AIDS

A special issue of the journal Prevention Science spotlights six NIDA-funded early interventions (delivered prior to the onset of adolescence) that successfully reduced later health-risking sexual behaviors related to HIV/AIDS.


Expanded HIV Screening Projected To Decrease Spread of the Virus

Intensified screening for HIV among injection drug users receiving opioid agonist therapy could prevent more than twice as many new infections as current screening practice. A recent study based on mathematical modeling found that screening every 6 months instead of annually, and adding viral RNA testing to the currently used HIV antibody testing, could improve both effectiveness and cost-effectiveness.

Study: Treat Jail Detainees’ Drug Abuse To Lower HIV Transmission

Active drug use before incarceration was associated with decreased engagement in HIV treatment among HIV-infected jail detainees. The severity of drug dependence correlated with worsening measures of engagement in HIV treatment. The study concludes that evidence-based treatment for drug abuse in jails may result in improved HIV treatment outcomes, which in turn could help slow HIV-transmission rates in the United States.

HIV Infection Accelerates Hepatitis C–Related Liver Fibrosis

Study patients with HIV­­–hepatitis C coinfection progressed to successive degrees of severity of liver fibrosis 9 years sooner than those infected with HCV alone. Further findings from the study suggest that suppressing HIV with antiretroviral medications may slow HCV-related liver fibrosis.

Study Endorses Onsite HIV Testing Without Risk Reduction Counseling

Patients were more likely to take a rapid HIV test when substance abuse treatment programs offered the test onsite rather than referred for offsite testing. Patients were equally likely to accept and learn their HIV status whether the offer of onsite testing was accompanied by 30 minutes of risk reduction counseling or by 5 minutes of brief information on the testing procedure. Onsite testing accompanied by brief information was cost effective, taking into account the projected lifetime costs of treatment and the gains in health and longevity for detected cases.

Seek-Test-Treat-Retain To Stop the Spread of HIV

NIDA Director Nora Volkow

Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

Antiretroviral Treatment Reduces Spread of HIV Among Injection Drug Users

Expanded use of antiretroviral therapy in British Columbia reduced the spread of HIV among injection drug users and others in the province.

Journal Highlights Global Nexus of Drug Abuse and HIV/AIDS

Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.

Pages

Subscribe to People with HIV or AIDS